Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Scutellaria tsinyunensis

ABSTRACT: cutellaria barbata Genome sequencing and assembly

PROVIDER: PRJNA680174 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13107290_1.fastq.gz	Fastqsanger.gz
	SRR13107290_2.fastq.gz	Fastqsanger.gz
	SRR13334746_1.fastq.gz	Fastqsanger.gz
	SRR13334746_2.fastq.gz	Fastqsanger.gz
	SRR13308149_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 9

Similar Datasets

Scutellaria barbata

Project description:Scutellaria barbata Genome sequencing and assembly

| PRJNA510902 | ENA

Scutellaria barbata isolate:Sbb2019

Project description:Scutellaria barbata isolate:Sbb2019 Genome sequencing and assembly

| PRJNA649842 | ENA

Scutellaria barbata

Project description:Scutellaria barbata overview

| PRJNA718935 | ENA

Scutellaria barbata

Project description:Scutellaria barbata Raw sequence reads

| PRJNA947595 | ENA

Scutellaria barbata cultivar:wild type

Project description:Scutellaria barbata cultivar:wild type Transcriptome or Gene expression

| PRJNA653305 | ENA

Scutellaria baicalensis

Project description:Scutellaria baicalensis Genome sequencing and assembly

| PRJNA510893 | ENA

Scutellaria baicalensis

Project description:Scutellaria baicalensis Genome sequencing and assembly

| PRJNA484052 | ENA

Scutellaria meehanioides

Project description:Scutellaria meehanioides Genome sequencing and assembly

| PRJNA715065 | ENA

Scutellaria baicalensis

Project description:Scutellaria baicalensis Genome sequencing

| PRJNA706192 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data